India's second-largest software services company, Infosys Technologies, for instance, plans to hire close to 30,000 this financial year.
Infosys, India's second-largest information technology services provider, believes winning two to five 'transformational' deals in the range of $30-80 million for the company every quarter could become a norm.
Tata Consultancy Services (TCS), Infosys Technologies and Wipro were eliminated from the selection process for the project on technical grounds. Another IT major, HCL Technologies, was also rejected. The size of the project is not yet known.
Elder Pharma employs about 3,300 people in India, with about 2,700 professionals in marketing and sales. This recruitment will help Elder Pharma to have one of the largest drug sales force in India, like market leaders such as Cipla, Ranbaxy, Piramal Healthcare and Lupin.
Polaris gets over 90 per cent of its revenue from exports. Till financial year 2009-10, the company did not actively think about a strategy to buy space in a special economic zone.
CanvasM, a joint venture between Tech Mahindra and Motorola, is planning to launch 6,000 new indigenously developed applications for mobile phones.
Players slash prices to leverage the popularity of IPL matches on the internet.
Cephalon, a US-based drug maker, has filed a lawsuit against Lupin Ltd and its US subsidiary Lupin Pharmaceuticals for challenging the patents on its sleep disorder drug Nuvigil.
Imagine this scenario. Pyarelal Shankar a grocery store owner in Haryana is not computer literate. Yet, he manages to regularly update his inventory online.
Bangalore-based information technology services firm MindTree has set up an ambitious target of becoming a $1-billion (around Rs 4,600-crore) company over the next five years.
Andrew Witty, chief executive of GlaxoSmithKline (GSK), the world's second-largest drug company, was in India this week as part of the dedication of an albandazole manufacturing facility at Nashik to the World Health Organization (WHO)'s global programme to eliminate Lymphatic Filariasis.
The recent case of embezzlement by a Wipro insider, believe industry experts and analysts, would have little impact on the company's business or image. However, they simultaneously caution that the issue yet again highlights the need for better measures on corporate governance and fraud.
The plethora of new pricing schemes from telecom companies, like 'one paisa per second' billing, has squeezed the margins of their business process outsourcing partners.
The proportion of women to men falls radically after the mid-management level.
Professional services firm Ernst & Young bagged the contract from UIDAI to become consulting partner for the project.
The increases are expected to be in the 8 to 12 per cent range, which do not compare too badly with the 13 to 15 per cent increments of pre-slowdown years such as 2007-08.
The project involves building a network around a dozen secured centres, each priced at pound 250 mn.
If most of the top 10 Indian drug companies were less than Rs 500-crore (Rs 5-billion) turnover ones a decade earlier and were focused only on domestic business, now they are companies with annual businesses ranging from Rs 2,000-Rs 6,000 crore (Rs 20-60 billion) and with operations spanning 60-100 countries and employing 3,000-5,000 people.
India's second largest IT company, Infosys Technologies, for instance, has narrowed on the new areas to drive its growth.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances